* En caso de que el paciente no tolere una dosis, se puede considerar prolongar el periodo antes de aumentar, o reducir temporalmente la dosis
Where we stand today (as of June 17, 2025): The enforcement discretion periods for both semaglutide and tirzepatide have ended
Formulated to promote mitochondrial function, this supplement supports both central and peripheral nervous system wellness for better mental clarity and emotional balance
Dial those in early, and you can shorten the adjustment window and keep performance from taking a hit
SURMOUNT-2 ket efficacy results, source: reference [2] Additionally, 81.6% (10 mg) and 86.4% (15 mg) of people taking tirzepatide achieved at least 5% body weight reduction , the other co-primary endpoint, compared to 30.5% of those taking placebo
This makes SLU-PP-332 a valuable tool in studies related to energy homeostasis, athletic endurance, and metabolic adaptation